🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Express Worries

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to individuals injecting products of unknown origin.

Several experts stated the demand for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.

Some content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Content Removal

According to TikTok, the platform has taken down problematic material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Operations

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home.

Within moments of entering one community, a vendor posted contact information, where most transactions occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or past usage.

Item Details and Pricing

Within these groups, messages show black plastic packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her staff has previously encountered patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially significant health risks”.